Search in Web Directory for "BRAF"
Your search matches the following sites:
BRAF v600e- clarientinc.com
The BRAF (V600E) mutation analysis is predictive for anti-EGFR therapies (i.e., cetuximab and panitumumab). BRAF mutations account for approximately 12-15% of colorectal cancer patients.
Keywords:
